Women receiving estrogen therapy are at increased risk of biliary tract disease, according to the results of a recent study of postmenopausal women. The analysis included 22,579 participants from ...

Medscape Medical News, October 05, 2023 Early-Onset NAFLD Tied to Higher Cancer Risk Earlier age at onset of nonalcoholic fatty liver disease was ... in Advanced Biliary Tract Cancers Newly ...

Tovecimig combined with paclitaxel showed a 17.1% response rate in biliary tract cancer, outperforming paclitaxel alone. The COMPANION-002 study reported lower progressive disease rates with tovecimig ...

The FDA has kicked off a priority review of AstraZeneca's checkpoint inhibitor Imfinzi for biliary tract cancer (BTC ... to live beyond five years. The disease can be asymptomatic in the early ...